Gj. Song et al., ALTERED CARDIAC ANNEXIN MESSENGER-RNA AND PROTEIN-LEVELS IN THE LEFT-VENTRICLE OF PATIENTS WITH END-STAGE HEART-FAILURE, Journal of Molecular and Cellular Cardiology, 30(3), 1998, pp. 443-451
Annexins are a unique family of membrane-associated, Ca2+ and phosphol
ipid-binding proteins found in various tissues. Among the 12 isoforms,
Annexin II, V and VI exist in heart tissue in the highest amounts. An
nexin VI has been shown to affect intracellular Ca2+ cycling and contr
actility in isolated cardiomyocytes. Annexin V is present in both card
iomyocytes and non-myocyte cell types in the heart and may play a role
in the regulation of cellular ion fluxes, organization and secretion,
while the cardiac effects of annexin II are unclear. To identify chan
ges in annexin II, V and VI isoforms that might occur in human heart f
ailure, we measured mRNA and protein levels of these three annexins in
transplanted left ventricular tissue of 12 patients with end-stage co
ngestive heart failure due to coronary artery disease (CAD, n = 6) or
idiopathic dilated cardiomyopathy (DCM, n = 6) who underwent cardiac t
ransplantation. Normal heart tissue (C, n = 6) was used as a control.
Northern blot analyses showed a significant decrease (61%) in annexin
VI mRNA levels in heart failure patients compared with controls (1.08
+/- 0.16 v 2.79 +/- 0.20 A.U.C. unit, determined by laser densitometry
, mean +/- S.E.). In contrast, we found a 67% increase (2.32 +/- 0.27
v 3.88 +/- 0.29) in annexin n mRNA levels and a two-fold increase (1.0
0 +/- 0.24 v 2.21 +/- 0.29) in annexin V mRNA levels in cardiomyopathi
c hearts as compared to normal hearts. Western blot analyses demonstra
ted a corresponding decrease (46.1%) in annexin VI protein levels in t
he heart failure group as compared to controls 12.63 +/- 0.22 v 4.88 /- 0.52), while annexin II protein levels showed a significant 40.7% i
ncrease in patients with heart failure compared to those in normal hea
rts (5.08 +/- 0.67 v, 3.61 +/- 0.32). Annexin V protein levels were al
so significantly increased (45%) in heart failure patients compared wi
th normal (2.14 +/- 0.19 v, 1.48 +/- 0.11). No difference in either an
nexins II, V or VI mRNA and protein levels were found between CAD and
DCM patients. We conclude that human end-stage heart failure is associ
ated with a down regulation of annexin VI and up regulation of annexin
II and V proteins. Coordinate changes were observed in steady-state m
RNA levels. These results suggest that these annexin isoforms may cont
ribute to the regulation of intracellular Ca2+ homeostasis in the card
iomyopathic heart. (C) 1998 Academic Press Limited.